- Home
- SCPH vs EDF Comparison
SCPH vs EDF Comparison
Compare SCPH & EDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- EDF
- Stock Information
- Founded
- SCPH 2013
- EDF 2010
- Country
- SCPH United States
- EDF United States
- Employees
- SCPH N/A
- EDF N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- EDF Investment Managers
- Sector
- SCPH Health Care
- EDF Finance
- Exchange
- SCPH Nasdaq
- EDF Nasdaq
- Market Cap
- SCPH 173.6M
- EDF 156.6M
- IPO Year
- SCPH 2017
- EDF N/A
- Fundamental
- Price
- SCPH $4.51
- EDF $5.02
- Analyst Decision
- SCPH Strong Buy
- EDF
- Analyst Count
- SCPH 3
- EDF 0
- Target Price
- SCPH $14.00
- EDF N/A
- AVG Volume (30 Days)
- SCPH 261.6K
- EDF 160.6K
- Earning Date
- SCPH 08-13-2025
- EDF 01-01-0001
- Dividend Yield
- SCPH N/A
- EDF 13.14%
- EPS Growth
- SCPH N/A
- EDF N/A
- EPS
- SCPH N/A
- EDF N/A
- Revenue
- SCPH $41,982,000.00
- EDF N/A
- Revenue This Year
- SCPH $108.95
- EDF N/A
- Revenue Next Year
- SCPH $73.83
- EDF N/A
- P/E Ratio
- SCPH N/A
- EDF N/A
- Revenue Growth
- SCPH 138.10
- EDF N/A
- 52 Week Low
- SCPH $1.94
- EDF $3.51
- 52 Week High
- SCPH $5.65
- EDF $5.50
- Technical
- Relative Strength Index (RSI)
- SCPH 60.01
- EDF 60.04
- Support Level
- SCPH $3.83
- EDF $5.00
- Resistance Level
- SCPH $4.18
- EDF $5.11
- Average True Range (ATR)
- SCPH 0.17
- EDF 0.05
- MACD
- SCPH -0.02
- EDF 0.00
- Stochastic Oscillator
- SCPH 76.60
- EDF 72.73
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About EDF Virtus Stone Harbor Emerging Markets Income Fund of Beneficial Interest
Virtus Stone Harbor Emerging Markets Income Fund is a closed-end management investment company. Its investment objective is to maximize total return, which consists of income from its investments and capital appreciation. The Fund normally will invest at least 80% of its net assets (plus any borrowings for investment purposes) in emerging markets securities.